help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manolagas, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manolagas, S. C.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Osteoporosis
Endocrine Reviews 21 (2): 115-137
Copyright © 2000 by The Endocrine Society

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis1

Stavros C. Manolagas

Division of Endocrinology & Metabolism, Center for Osteoporosis & Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205, USA

The adult skeleton regenerates by temporary cellular structures that comprise teams of juxtaposed osteoclasts and osteoblasts and replace periodically old bone with new. A considerable body of evidence accumulated during the last decade has shown that the rate of genesis of these two highly specialized cell types, as well as the prevalence of their apoptosis, is essential for the maintenance of bone homeostasis; and that common metabolic bone disorders such as osteoporosis result largely from a derangement in the birth or death of these cells. The purpose of this article is 3-fold: 1) to review the role and the molecular mechanism of action of regulatory molecules, such as cytokines and hormones, in osteoclast and osteoblast birth and apoptosis; 2) to review the evidence for the contribution of changes in bone cell birth or death to the pathogenesis of the most common forms of osteoporosis; and 3) to highlight the implications of bone cell birth and death for a better understanding of the mechanism of action and efficacy of present and future pharmacotherapeutic agents for osteoporosis.




This article has been cited by other articles:


Home page
 haematolHome page
M. Di Rocco, F. Giona, F. Carubbi, S. Linari, F. Minichilli, R. O. Brady, G. Mariani, and M. D. Cappellini
A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease
Haematologica, August 1, 2008; 93(8): 1211 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
S E Papapoulos and R C Schimmer
Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate
Postgrad. Med. J., June 1, 2008; 84(992): 307 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. D. Nerenz, M. L. Martowicz, and J. W. Pike
An Enhancer 20 Kilobases Upstream of the Human Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Mediates Dominant Activation by 1,25-Dihydroxyvitamin D3
Mol. Endocrinol., May 1, 2008; 22(5): 1044 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Dufour, X. Holy, and P. J. Marie
Transforming growth factor-{beta} prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling
Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E794 - E801.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Sneve, N. Emaus, R. M. Joakimsen, and R. Jorde
The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: the Tromso Study
Eur. J. Endocrinol., March 1, 2008; 158(3): 401 - 409.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. Tam, V. Trembovler, V. Di Marzo, S. Petrosino, G. Leo, A. Alexandrovich, E. Regev, N. Casap, A. Shteyer, C. Ledent, et al.
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling
FASEB J, January 1, 2008; 22(1): 285 - 294.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Horsch, H. de Wet, M. M. Schuurmans, F. Allie-Reid, A. C. B. Cato, J. Cunningham, J. M. Burrin, F. S. Hough, and P. A. Hulley
Mitogen-Activated Protein Kinase Phosphatase 1/Dual Specificity Phosphatase 1 Mediates Glucocorticoid Inhibition of Osteoblast Proliferation
Mol. Endocrinol., December 1, 2007; 21(12): 2929 - 2940.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Vega, N. M. Maalouf, and K. Sakhaee
The Role of Receptor Activator of Nuclear Factor-{kappa}B (RANK)/RANK Ligand/Osteoprotegerin: Clinical Implications
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4514 - 4521.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M M Conradie, H de Wet, D D R Kotze, J M Burrin, F S Hough, and P A Hulley
Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo
J. Endocrinol., November 1, 2007; 195(2): 229 - 240.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. C. Manolagas and M. Almeida
Gone with the Wnts: {beta}-Catenin, T-Cell Factor, Forkhead Box O, and Oxidative Stress in Age-Dependent Diseases of Bone, Lipid, and Glucose Metabolism
Mol. Endocrinol., November 1, 2007; 21(11): 2605 - 2614.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
I. A. BAB
Regulation of Skeletal Remodeling by the Endocannabinoid System
Ann. N.Y. Acad. Sci., November 1, 2007; 1116(1): 414 - 422.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Almeida, L. Han, M. Martin-Millan, L. I. Plotkin, S. A. Stewart, P. K. Roberson, S. Kousteni, C. A. O'Brien, T. Bellido, A. M. Parfitt, et al.
Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids
J. Biol. Chem., September 14, 2007; 282(37): 27285 - 27297.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Almeida, L. Han, M. Martin-Millan, C. A. O'Brien, and S. C. Manolagas
Oxidative Stress Antagonizes Wnt Signaling in Osteoblast Precursors by Diverting beta-Catenin from T Cell Factor- to Forkhead Box O-mediated Transcription
J. Biol. Chem., September 14, 2007; 282(37): 27298 - 27305.
[Abstract] [Full Text] [PDF]

Home page
 J Am Acad Orthop SurgHome page
S. B. Goodman, W. Jiranek, E. Petrow, and A. W. Yasko
The Effects of Medications on Bone
J. Am. Acad. Ortho. Surg., August 1, 2007; 15(8): 450 - 460.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
S E Papapoulos and R C Schimmer
Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate
Ann Rheum Dis, July 1, 2007; 66(7): 853 - 858.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. M. Sharma, A. Bronisz, R. Hu, K. Patel, K. C. Mansky, S. Sif, and M. C. Ostrowski
MITF and PU.1 Recruit p38 MAPK and NFATc1 to Target Genes during Osteoclast Differentiation
J. Biol. Chem., May 25, 2007; 282(21): 15921 - 15929.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. Ishijima, K. Tsuji, S. R Rittling, T. Yamashita, H. Kurosawa, D. T Denhardt, A. Nifuji, Y. Ezura, and M. Noda
Osteopontin is required for mechanical stress-dependent signals to bone marrow cells
J. Endocrinol., May 1, 2007; 193(2): 235 - 243.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. J. Xian
Roles of Epidermal Growth Factor Family in the Regulation of Postnatal Somatic Growth
Endocr. Rev., May 1, 2007; 28(3): 284 - 296.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
P. Chavassieux, E. Seeman, and P. D. Delmas
Insights into Material and Structural Basis of Bone Fragility from Diseases Associated with Fractures: How Determinants of the Biomechanical Properties of Bone Are Compromised by Disease
Endocr. Rev., April 1, 2007; 28(2): 151 - 164.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. S. Perrien, N. S. Akel, P. K. Edwards, A. A. Carver, M. S. Bendre, F. L. Swain, R. A. Skinner, W. R. Hogue, K. M. Nicks, T. M. Pierson, et al.
Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength
Endocrinology, April 1, 2007; 148(4): 1654 - 1665.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
G. YOUSEFZADEH, B. LARIJANI, A. MOHAMMADIRAD, R. HESHMAT, G. DEHGHAN, R. RAHIMI, and M. ABDOLLAHI
Determination of Oxidative Stress Status and Concentration of TGF-beta1 in the Blood and Saliva of Osteoporotic Subjects
Ann. N.Y. Acad. Sci., December 1, 2006; 1091(1): 142 - 150.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
D. J. HADJIDAKIS and I. I. ANDROULAKIS
Bone Remodeling
Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 385 - 396.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J.-R. Chen, R. L. Haley, M. Hidestrand, K. Shankar, X. Liu, C. K. Lumpkin, P. M. Simpson, T. M. Badger, and M. J. J. Ronis
Estradiol Protects against Ethanol-Induced Bone Loss by Inhibiting Up-Regulation of Receptor Activator of Nuclear Factor-{kappa}B Ligand in Osteoblasts
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1182 - 1190.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. R. Weisinger, R. G. Carlini, E. Rojas, and E. Bellorin-Font
Bone Disease after Renal Transplantation
Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1300 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Kim, M. Yamazaki, L. A. Zella, N. K. Shevde, and J. W. Pike
Activation of Receptor Activator of NF-{kappa}B Ligand Gene Expression by 1,25-Dihydroxyvitamin D3 Is Mediated through Multiple Long-Range Enhancers.
Mol. Cell. Biol., September 1, 2006; 26(17): 6469 - 6486.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Grassi, X. Fan, J. Rahnert, M. N. Weitzmann, R. Pacifici, M. S. Nanes, and J. Rubin
Bone Re/Modeling Is More Dynamic in the Endothelial Nitric Oxide Synthase(-/-) Mouse
Endocrinology, September 1, 2006; 147(9): 4392 - 4399.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. J. Allison, P. Baldock, A. Sainsbury, R. Enriquez, N. J. Lee, E.-J. D. Lin, M. Klugman, M. During, J. A. Eisman, M. Li, et al.
Conditional Deletion of Hypothalamic Y2 Receptors Reverts Gonadectomy-induced Bone Loss in Adult Mice
J. Biol. Chem., August 18, 2006; 281(33): 23436 - 23444.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. M. Rahman, A. Bhattacharya, and G. Fernandes
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling
J. Lipid Res., August 1, 2006; 47(8): 1739 - 1748.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
U.H. Lerner
Bone Remodeling in Post-menopausal Osteoporosis.
J. Dent. Res., July 1, 2006; 85(7): 584 - 595.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
E. Seeman and P. D. Delmas
Bone quality--the material and structural basis of bone strength and fragility.
N. Engl. J. Med., May 25, 2006; 354(21): 2250 - 2261.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. S. Perrien, S. J. Achenbach, S. E. Bledsoe, B. Walser, L. J. Suva, S. Khosla, and D. Gaddy
Bone Turnover across the Menopause Transition: Correlations with Inhibins and Follicle-Stimulating Hormone
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1848 - 1854.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
T.J. MARTIN, J.M.W. QUINN, M.T. GILLESPIE, K.W. NG, M.A. KARSDAL, and N.A. SIMS
Mechanisms Involved in Skeletal Anabolic Therapies
Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 458 - 470.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Almeida, L. Han, C. A. O'Brien, S. Kousteni, and S. C. Manolagas
Classical Genotropic Versus Kinase-Initiated Regulation of Gene Transcription by the Estrogen Receptor {alpha}
Endocrinology, April 1, 2006; 147(4): 1986 - 1996.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. A. Phadke, R. R. Mercer, J. F. Harms, Y. Jia, A. R. Frost, J. L. Jewell, K. M. Bussard, S. Nelson, C. Moore, J. C. Kappes, et al.
Kinetics of Metastatic Breast Cancer Cell Trafficking in Bone
Clin. Cancer Res., March 1, 2006; 12(5): 1431 - 1440.
[Abstract] [Full Text] [PDF]

Home page
 IBMS BoneKEyHome page
S. C. Manolagas
Choreography from the Tomb: An Emerging Role of Dying Osteocytes in the Purposeful, and Perhaps Not So Purposeful, Targeting of Bone Remodeling
IBMS BoneKEy, January 1, 2006; 3(1): 5 - 14.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Ha, J.-H. Lee, H.-N. Kim, H.-M. Kim, H. B. Kwak, S. Lee, H.-H. Kim, and Z. H. Lee
{alpha}-Lipoic Acid Inhibits Inflammatory Bone Resorption by Suppressing Prostaglandin E2 Synthesis
J. Immunol., January 1, 2006; 176(1): 111 - 117.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Liu, S. Wang, S. Wei, L. Sun, and X. Feng
Receptor Activator of NF-{kappa}B (RANK) Cytoplasmic Motif, 369PFQEP373, Plays a Predominant Role in Osteoclast Survival in Part by Activating Akt/PKB and Its Downstream Effector AFX/FOXO4
J. Biol. Chem., December 30, 2005; 280(52): 43064 - 43072.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Young, N. Mikhalkevich, Y. Yan, D. Chen, and W.-p. Zheng
Differential Regulation of Osteoblast Activity by Th Cell Subsets Mediated by Parathyroid Hormone and IFN-{gamma}
J. Immunol., December 15, 2005; 175(12): 8287 - 8295.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Bellido, A. A. Ali, I. Gubrij, L. I. Plotkin, Q. Fu, C. A. O'Brien, S. C. Manolagas, and R. L. Jilka
Chronic Elevation of Parathyroid Hormone in Mice Reduces Expression of Sclerostin by Osteocytes: A Novel Mechanism for Hormonal Control of Osteoblastogenesis
Endocrinology, November 1, 2005; 146(11): 4577 - 4583.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Bajayo, I. Goshen, S. Feldman, V. Csernus, K. Iverfeldt, E. Shohami, R. Yirmiya, and I. Bab
Central IL-1 receptor signaling regulates bone growth and mass
PNAS, September 6, 2005; 102(36): 12956 - 12961.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. Gazzerro, V. Deregowski, S. Vaira, and E. Canalis
Overexpression of Twisted Gastrulation Inhibits Bone Morphogenetic Protein Action and Prevents Osteoblast Cell Differentiation in Vitro
Endocrinology, September 1, 2005; 146(9): 3875 - 3882.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
L. I. Plotkin, I. Mathov, J. I. Aguirre, A. M. Parfitt, S. C. Manolagas, and T. Bellido
Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs
Am J Physiol Cell Physiol, September 1, 2005; 289(3): C633 - C643.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. P Shrader and K. R Ragucci
Parathyroid Hormone (1-84) and Treatment of Osteoporosis
Ann. Pharmacother., September 1, 2005; 39(9): 1511 - 1516.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Wu, E.-Y. Ahn, M. A. McKenna, H. Yeo, and J. M. McDonald
Fas Binding to Calmodulin Regulates Apoptosis in Osteoclasts
J. Biol. Chem., August 19, 2005; 280(33): 29964 - 29970.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Y. Han, N. K. Lee, K. H. Kim, I. W. Jang, M. Yim, J. H. Kim, W. J. Lee, and S. Y. Lee
Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis
Blood, August 15, 2005; 106(4): 1240 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
D. Karasik, S. Demissie, L. A. Cupples, and D. P. Kiel
Disentangling the Genetic Determinants of Human Aging: Biological Age as an Alternative to the Use of Survival Measures
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2005; 60(5): 574 - 587.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. E. Broker, F. A.E. Kruyt, and G. Giaccone
Cell Death Independent of Caspases: A Review
Clin. Cancer Res., May 1, 2005; 11(9): 3155 - 3162.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. M. Vertino, C. M. Bula, J.-R. Chen, M. Almeida, L. Han, T. Bellido, S. Kousteni, A. W. Norman, and S. C. Manolagas
Nongenotropic, Anti-Apoptotic Signaling of 1{alpha},25(OH)2-Vitamin D3 and Analogs through the Ligand Binding Domain of the Vitamin D Receptor in Osteoblasts and Osteocytes: MEDIATION BY Src, PHOSPHATIDYLINOSITOL 3-, AND JNK KINASES
J. Biol. Chem., April 8, 2005; 280(14): 14130 - 14137.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
Y. M. Alkhiary, L. C. Gerstenfeld, E. Krall, M. Westmore, M. Sato, B. H. Mitlak, and T. A. Einhorn
Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34)
J. Bone Joint Surg. Am., April 1, 2005; 87(4): 731 - 741.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Schneider, L. M. Kalikin, A. C. Mattos, E. T. Keller, M. J. Allen, K. J. Pienta, and L. K. McCauley
Bone Turnover Mediates Preferential Localization of Prostate Cancer in the Skeleton
Endocrinology, April 1, 2005; 146(4): 1727 - 1736.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
L. Fontana, J. L. Shew, J. O. Holloszy, and D. T. Villareal
Low Bone Mass in Subjects on a Long-term Raw Vegetarian Diet
Arch Intern Med, March 28, 2005; 165(6): 684 - 689.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
K. Kaabeche, H. Guenou, D. Bouvard, N. Didelot, A. Listrat, and P. J. Marie
Cbl-mediated ubiquitination of {alpha}5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation
J. Cell Sci., March 15, 2005; 118(6): 1223 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
H. Zhao, F. P. Ross, and S. L. Teitelbaum
Unoccupied {alpha}v{beta}3 Integrin Regulates Osteoclast Apoptosis by Transmitting a Positive Death Signal
Mol. Endocrinol., March 1, 2005; 19(3): 771 - 780.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Ohishi, Y. Matsumura, D. Aki, R. Mashima, K. Taniguchi, T. Kobayashi, T. Kukita, Y. Iwamoto, and A. Yoshimura
Suppressors of Cytokine Signaling-1 and -3 Regulate Osteoclastogenesis in the Presence of Inflammatory Cytokines
J. Immunol., March 1, 2005; 174(5): 3024 - 3031.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-R. Chen, L. I. Plotkin, J. I. Aguirre, L. Han, R. L. Jilka, S. Kousteni, T. Bellido, and S. C. Manolagas
Transient Versus Sustained Phosphorylation and Nuclear Accumulation of ERKs Underlie Anti-Versus Pro-apoptotic Effects of Estrogens
J. Biol. Chem., February 11, 2005; 280(6): 4632 - 4638.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Endocr. Rev., February 1, 2005; 26(1): 114 - 146.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Matsumoto, M. Kogawa, S. Wada, H. Takayanagi, M. Tsujimoto, S. Katayama, K. Hisatake, and Y. Nogi
Essential Role of p38 Mitogen-activated Protein Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1
J. Biol. Chem., October 29, 2004; 279(44): 45969 - 45979.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S P Conway, B Oldroyd, A Morton, J G Truscott, and D G Peckham
Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study
Thorax, August 1, 2004; 59(8): 699 - 703.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. W. Goderie-Plomp, M. van der Klift, W. de Ronde, A. Hofman, F. H. de Jong, and H. A. P. Pols
Endogenous Sex Hormones, Sex Hormone-Binding Globulin, and the Risk of Incident Vertebral Fractures in Elderly Men and Women: The Rotterdam Study
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3261 - 3269.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Stossi, D. H. Barnett, J. Frasor, B. Komm, C. R. Lyttle, and B. S. Katzenellenbogen
Transcriptional Profiling of Estrogen-Regulated Gene Expression via Estrogen Receptor (ER) {alpha} or ER{beta} in Human Osteosarcoma Cells: Distinct and Common Target Genes for These Receptors
Endocrinology, July 1, 2004; 145(7): 3473 - 3486.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson
Androgens and Bone
Endocr. Rev., June 1, 2004; 25(3): 389 - 425.
[Abstract] [Full Text] [PDF]

Home page